Stockscreener 앱 받기
34.43
3.67%
1.22
시간 외 거래:
34.80
0.37
+1.07%
전일 마감가:
$33.21
열려 있는:
$33.54
하루 거래량:
531.11K
Relative Volume:
1.19
시가총액:
$1.26B
수익:
$154.15M
순이익/손실:
$-33.58M
주가수익비율:
-35.86
EPS:
-0.96
순현금흐름:
$-20.74M
1주 성능:
+10.25%
1개월 성능:
+11.03%
6개월 성능:
+11.03%
1년 성능:
+1.50%
1일 변동 폭
$32.91
$35.33
1주일 범위
$31.24
$35.33
52주 변동 폭
$20.85
$59.23
Harrow Inc Stock (HROW) Company Profile
명칭
Harrow Inc
전화
615.733.4731
주소
1A BURTON HILLS BLVD, NASHVILLE, CA
HROW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
34.43 | 1.21B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 개시 | BTIG Research | Buy |
| 2025-06-10 | 개시 | William Blair | Outperform |
| 2025-02-06 | 개시 | H.C. Wainwright | Buy |
| 2024-12-04 | 재확인 | B. Riley Securities | Buy |
| 2024-04-11 | 개시 | Craig Hallum | Buy |
| 2022-09-08 | 재개 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-09-24 | 개시 | Aegis Capital | Buy |
| 2021-07-02 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Harrow Inc 주식(HROW)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW - Bluefield Daily Telegraph
A Preview Of Harrow's Earnings - 富途牛牛
Harrow, Inc. shares fall 1.82% intraday after announcing participation in H.C. Wainwright’s 5th Annual Ophthalmology Conference. - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc.HROW - WV News
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Co - GuruFocus
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference - The Manila Times
Harrow Executives Reveal Future of Eye Care: Double Feature at Major Ophthalmology Conference - Stock Titan
Insider Backed Growth Companies To Watch Now - simplywall.st
Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
How volatile is Harrow Inc. stock compared to the marketDiscover the next big stock winners - Jammu Links News
What makes Harrow Inc. stock price move sharplyAchieve breakthrough profits with expert advice - Jammu Links News
Is Harrow Inc. a growth stock or a value stockUncover the best stocks for explosive growth - Jammu Links News
What drives Harrow Inc. stock priceHigh-performance stocks for savvy investors - Jammu Links News
What is the dividend policy of Harrow Inc. stockInvest smarter with comprehensive market analysis - Jammu Links News
What is Harrow Inc. company’s growth strategyBuild wealth faster with expert stock picks - Jammu Links News
While Harrow (NASDAQ:HROW) Shareholders Have Made 432% in 5 Years, Increasing Losses Might Now Be Front of Mind as Stock Sheds 14% This Week - 富途牛牛
Published on: 2025-08-03 17:16:02 - Jammu Links News
What are the latest earnings results for Harrow Inc.Invest confidently with professional guidance - Jammu Links News
What are Harrow Inc. company’s key revenue driversInvest confidently with expert support - Jammu Links News
What analysts say about Harrow Inc. stockDiscover stocks with explosive growth potential - Jammu Links News
What catalysts could drive Harrow Inc. stock higher in 2025Unlock daily stock market insights for success - Jammu Links News
Does Harrow Inc. stock perform well during market downturnsAccess exclusive market insights for free - Jammu Links News
How does Harrow Inc. generate profit in a changing economyDiscover hidden gems in the stock market - Jammu Links News
What is the risk reward ratio of investing in Harrow Inc. stockMaximize returns with timely market signals - Jammu Links News
What are analysts’ price targets for Harrow Inc. in the next 12 monthsUnlock superior stock analysis tools - Jammu Links News
What markets is Harrow Inc. expanding into Is Zedge Inc. stock a good long term investment optionAdvanced Screener Growth Plan For Every Investor - Jammu Links News
When is Harrow Inc. stock expected to show significant growthPre Market Insights For Beginners - Jammu Links News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW - GlobeNewswire Inc.
Is Harrow Inc. stock overvalued or undervaluedBeginner Investor Ideas For Smart Trading - jammulinksnews.com
What are the technical indicators suggesting about Harrow Inc.AI Powered Strategy For 2025 - Jammu Links News
What Fibonacci levels say about Harrow Inc. reboundTrade Timing Strategy With Technical Data Explained - metal.it
Candlestick Reversal Detected on Harrow Inc.’s ChartSwing Setup With Technical Confirmation Explained - metal.it
Harrow to Release Q2 2025 Financial Results on August 11, 2025 - AInvest
Can Harrow Inc. Outperform Peers After Recent PullbackStock Portfolio Allocation Guidance for Volatile Markets - metal.it
Institutional owners may ignore Harrow, Inc.'s (NASDAQ:HROW) recent US$81m market cap decline as longer-term profits stay in the green - simplywall.st
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 - GlobeNewswire
Leading Eyecare Pharma Harrow Sets Q2 Earnings Release: Key Details for Investors - Stock Titan
Why Harrow Inc. stock attracts strong analyst attentionDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
Real time social sentiment graph for Harrow Inc.Swing Trade Entry With Volume Triggers Released - metal.it
Published on: 2025-07-28 19:53:29 - metal.it
Why Harrow Inc. stock is on top investor watchlistsCarefully Curated High Return Stocks - beatles.ru
Harrow Inc (HROW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):